GT BIOPHARMA, INC. Total Assets
GT BIOPHARMA, INC. (GTBP) had Total Assets of $8.11 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-03-06
- 2025-12-31: Assets $8.11M.
- 2025-09-30: Assets $4.32M.
- 2025-06-30: Assets $7.12M.
- 2024-12-31: Assets $4.23M.
| Period end | Assets |
|---|---|
| 2025-12-31 | $8.11M 10-K · filed 2026-03-02 |
| 2025-09-30 | $4.32M 10-Q/A · filed 2026-03-06 |
| 2025-06-30 | $7.12M 10-Q/A · filed 2026-03-06 |
| 2024-12-31 | $4.23M 10-K · filed 2026-03-02 |
| 2024-09-30 | $6.76M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $9.27M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $9.91M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $14.11M 10-K · filed 2025-02-21 |
| 2023-09-30 | $16.15M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $18.14M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $20.09M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $16.74M 10-K · filed 2024-03-26 |
| 2022-09-30 | $21.07M 10-Q · filed 2022-10-31 |
| 2022-06-30 | $24.17M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $27.44M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $32.17M 10-K · filed 2023-03-30 |
| 2020-12-31 | $5.66M 10-K · filed 2021-04-16 |
| 2020-09-30 | $917.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.06M 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $295.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $396.00K 10-K · filed 2021-04-16 |
| 2019-09-30 | $482.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $25.71M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $25.54M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $25.40M 10-K · filed 2020-03-27 |
| 2018-09-30 | $26.54M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $255.01M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $257.33M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $254.37M 10-K · filed 2019-03-29 |
| 2017-09-30 | $256.52M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $42.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $238.00K 10-Q · filed 2017-04-28 |
| 2016-12-31 | $25.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $160.00K 10-Q/A · filed 2018-02-28 |
| 2016-06-30 | $362.00K 10-Q/A · filed 2018-02-28 |
| 2016-03-31 | $37.00K 10-Q/A · filed 2018-02-28 |
| 2015-12-31 | $54.00K 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $49.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $132.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $1.43M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $888.00K 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $710.00K 10-Q · filed 2015-01-08 |
| 2014-06-30 | $52.00K 10-Q · filed 2015-01-08 |
| 2014-03-31 | $103.00K 10-Q · filed 2015-01-08 |
| 2013-12-31 | $147.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $62.00K 10-Q · filed 2014-12-17 |
| 2013-06-30 | $154.00K 10-Q · filed 2014-12-12 |
| 2013-03-31 | $118.00K 10-Q · filed 2014-12-10 |
| 2012-12-31 | $226.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | $88.00K 10-Q · filed 2012-11-21 |
| 2012-06-30 | $125.00K 10-Q/A · filed 2012-09-13 |
| 2012-03-31 | $166.00K 10-Q · filed 2012-05-21 |
| 2011-12-31 | $129.00K 10-K · filed 2014-11-18 |
| 2011-09-30 | $371.00K 10-Q · filed 2011-11-21 |
| 2011-06-30 | $228.00K 10-Q/A · filed 2011-09-12 |
| 2010-12-31 | $185.00K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |